Cargando…

A role for the Epstein–Barr virus in multiple sclerosis aetiology?

Detalles Bibliográficos
Autores principales:	Hrastelj, J., Robertson, N. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152828/ https://www.ncbi.nlm.nih.gov/pubmed/35639199 http://dx.doi.org/10.1007/s00415-022-11177-w

Ejemplares similares

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

Ice bucket challenge bears fruit for amyotrophic lateral sclerosis
por: Hrastelj, James, et al.
Publicado: (2016)

Socioeconomic status in neurological disorders: a modifiable risk factor?
por: Hrastelj, J., et al.
Publicado: (2022)

Vaccine-induced immune thrombosis and thrombocytopaenia: incidence, mechanism and treatment
por: Hrastelj, J., et al.
Publicado: (2021)

Advances in the genetics of stroke risk and recovery
por: Majumder, Sabbiha Nadia, et al.
Publicado: (2022)

Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia
por: Saw, Aung M., et al.
Publicado: (2023)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

Continuous evolution of magnetic resonance imaging in multiple sclerosis
por: Tallantyre, E. C., et al.
Publicado: (2016)

Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

New rare genetic variants in multiple sclerosis
por: Harding, Katharine E., et al.
Publicado: (2018)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

Advances in the use of stem cell transplants in the treatment of multiple sclerosis
por: Thomas, Rachel, et al.
Publicado: (2022)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
por: Kreft, Karim L., et al.
Publicado: (2022)

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
por: Willis, M. D., et al.
Publicado: (2020)

Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?
por: Fung, W., et al.
Publicado: (2018)

Amyotrophic lateral sclerosis: an update on treatments from clinical trials
por: Wynford-Thomas, Ray, et al.
Publicado: (2023)

Zika virus and neurology: proving cause and effect
por: Massey, T. H., et al.
Publicado: (2016)

Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
por: McArthur, C., et al.
Publicado: (2023)

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts
por: M, Hu, et al.
Publicado: (2020)

Preclinical retinal neurodegeneration in a model of multiple sclerosis: The Journal of Neuroscience 2012; 32(16):5585–5597
por: Mathur, Deepali, et al.
Publicado: (2012)

Cerebral amyloid angiopathy: subtypes, treatment and role in cognitive impairment
por: McLauchlan, D., et al.
Publicado: (2017)

The role of TSPO PET in assessing neuroinflammation
por: Crawshaw, Ania A., et al.
Publicado: (2017)

The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
por: Wynford-Thomas, Ray, et al.
Publicado: (2015)

Dystonia: opportunities to gain insights into underlying pathophysiological mechanisms
por: Peall, K. J., et al.
Publicado: (2017)

MRI-guided focused ultrasound: new hope for drug-resistant neurological conditions
por: Bari, S., et al.
Publicado: (2023)

Clinical trials in myasthenia gravis
por: Mahmood, A., et al.
Publicado: (2023)

Clinical patterns in CADASIL
por: Gailani, G., et al.
Publicado: (2022)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

Why antisense could make sense for neurodegeneration
por: Massey, T. H., et al.
Publicado: (2017)

Restless legs syndrome: causes and consequences
por: Massey, T. H., et al.
Publicado: (2020)

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2
por: Cauchi, M., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Neurological complications of COVID-19: a preliminary review
por: Pryce-Roberts, A., et al.
Publicado: (2020)

The economic burden of chronic neurological disease
por: Wynford-Thomas, R., et al.
Publicado: (2017)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Anti-epileptics and pregnancy: an update
por: Al-Ansari, A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2hkgmranaj7v6ld8rlv5qov9iv